ir.syndax.comInvestors | Syndax Pharmaceuticals, Inc.
ir.syndax.com Profile
ir.syndax.com
Maindomain:syndax.com
Title:Investors | Syndax Pharmaceuticals, Inc.
Description：The Investor Relations website contains information about Syndax Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts.
Discover ir.syndax.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.syndax.com Information
| Website / Domain: | ir.syndax.com |
| HomePage size: | 59.153 KB |
| Page Load Time: | 0.561393 Seconds |
| Website IP Address: | 23.208.37.53 |
| Isp Server: | Akamai Technologies Inc. |
ir.syndax.com Ip Information
| Ip Country: | United States |
| City Name: | New York City |
| Latitude: | 40.71427154541 |
| Longitude: | -74.005966186523 |
ir.syndax.com Keywords accounting
| Keyword | Count |
|---|
ir.syndax.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1616174822" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Fri, 19 Mar 2021 17:27:02 GMT |
| Link: http://ir.syndax.com/; rel="shortlink", http://ir.syndax.com/; rel="canonical", http://ir.syndax.com/investor-relations; rel="alternate"; hreflang="en", http://ir.syndax.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| X-Age: 0 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Request-ID: v-51b2529c-88d8-11eb-93b0-a7a77a7807be |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 12448 |
| Cache-Control: public, max-age=0, s-maxage=2700 |
| Expires: Fri, 19 Mar 2021 17:27:03 GMT |
| Date: Fri, 19 Mar 2021 17:27:03 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
ir.syndax.com Meta Info
| charset="utf-8"/ |
| content="Syndax Pharmaceuticals, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about Syndax Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="http://ir.syndax.com/investor-relations" property="og:url"/ |
| content="Investors | Syndax Pharmaceuticals, Inc." property="og:title"/ |
| content="no-referrer" name="referrer"/ |
| content="The Investor Relations website contains information about Syndax Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts." property="og:description"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
23.208.37.53 Domains
| Domain | WebSite Title |
|---|
ir.syndax.com Similar Website
| Domain | WebSite Title |
|---|---|
| ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices | |
| Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals | |
| Lifeline Pharmaceuticals, LLCâs Login Page | Lifeline Pharmaceuticals, LLC | |
| Welcome - NeilMed Pharmaceuticals, Inc. | |
| About Titan Pharmaceuticals Titan Pharmaceuticals Inc | |
| Actelion Pharmaceuticals US, Inc | |
| Spectrum Pharmaceuticals, Inc. | |
| Avadel Pharmaceuticals | |
| Hepion Pharmaceuticals | |
| Akorn Pharmaceuticals | |
| Home | Pharmaceuticals | |
| INOVIO Pharmaceuticals | |
| Overview | Cyclacel Pharmaceuticals, Inc. | |
| Ironwood Pharmaceuticals, Inc. - Home | |
| Investors | Syndax Pharmaceuticals, Inc. |
ir.syndax.com Traffic Sources Chart
ir.syndax.com Alexa Rank History Chart
ir.syndax.com Html To Plain Text
Skip to main navigation Home About Us Back About Us Leadership Board of Directors Scientific Advisory Board Vision, Mission, and Values Pipeline Back Pipeline SNDX-5613 Axatilimab Entinostat Publications & Meeting Presentations Clinical Trials Back Clinical Trials SNDX-5613 Clinical Trials Axatilimab Clinical Trials Compassionate Use Patients & Caregivers Investors Contact Us Contact Us About Pipeline Clinical Trials Patients & Caregivers Investors Join Us Investors Investors Investor Relations Investors Press Releases Events & Presentations Corporate Governance Management Board of Directors Committee Composition Contact the Board Financial Information SEC Filings Annual Reports and Proxies Quarterly Results Key Ratios Stock Information Historic Stock Lookup Investment Calculator Analyst Coverage Ownership Profile FAQs Contact Us Investors Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Through our pipeline agents, entinostat, a late stage, class 1 specific HDAC inhibitor and SNDX-6352, a phase 1 anti-CSF-1R monoclonal antibody, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax corporate headquarters are in Waltham, MA. : Day High: Day Low: Volume: Data Provided by Refinitiv. Minimum 15 minutes delayed. Intra 3 mo. 6 mo. 1 yr. Press Releases 03.08.21 Syndax Pharmaceuticals Reports Fourth Quarter 2020 Financial Results and Provides Clinical and Business Update 03.01.21 Syndax to Announce Fourth Quarter and Year-end 2020 Financial Results and Host Conference Call and Webcast on March 8, 2021 02.24.21 Syndax Announces Participation at Two Upcoming Investor Conferences 12.18.20 Syndax Pharmaceuticals To Be Added to the NASDAQ Biotechnology Index View all press releases Events & Presentations 03.09.21 / 3:35 PM EST Barclays Global Healthcare Conference 03.08.21 / 4:30 PM EST Syndax Fourth Quarter 2020 Conference Call 03.03.21 / 11:40 AM EST Cowen 41st Annual Health Care Conference View all events & presentations Shareholder Tools Printed Materials Email Alerts RSS Print Share Search Facebook Google LinkedIn Twitter RSS © 2021 Syndax | Terms of Use | Privacy Policy | Site Map About Us Pipeline News Investors Careers...
ir.syndax.com Whois
"domain_name": "SYNDAX.COM",
"registrar": "Register.com, Inc.",
"whois_server": "whois.register.com",
"referral_url": null,
"updated_date": [
"2020-06-22 13:54:07",
"2020-06-22 13:55:37"
],
"creation_date": "2004-06-29 16:20:00",
"expiration_date": "2021-06-29 16:20:00",
"name_servers": [
"NICK.NS.CLOUDFLARE.COM",
"TANI.NS.CLOUDFLARE.COM"
],
"status": "clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"emails": [
"abuse@web.com",
"58054106@myprivatename.com",
"58038613@myprivatename.com"
],
"dnssec": "unsigned",
"name": "PERFECT PRIVACY, LLC",
"org": null,
"address": "5335 Gate Parkway care of REGISTER.COM",
"city": "Jacksonville",
"state": "FL",
"zipcode": "32256",
"country": "US"